Breaking News Instant updates and real-time market news.

GHDX

Genomic Health

$31.29

0.15 (0.48%)

08:21
03/30/18
03/30
08:21
03/30/18
08:21

Epic, Genomic announce favorable draft local coverage determination

Epic Sciences and Genomic Health (GHDX) announced that Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a draft local coverage determination for the Oncotype DX AR-V7 Nucleus Detect test. The draft LCD recommends Medicare coverage for use of the test throughout the United States to help determine which patients with metastatic castration-resistant prostate cancer may benefit from androgen receptor signaling inhibitor (ARSi) therapy and which may benefit from chemotherapy, the companies said in a statement. The Oncotype DX AR-V7 Nucleus Detect test is a circulating tumor cell-based, liquid biopsy test that is commercially available in the United States through Epic's partnership with Genomic Health. "Prior to the Oncotype DX AR-V7 Nucleus Detect test, there was no clear consensus on therapeutic sequencing after initial exposure to an ARSi therapy, and the most common clinical decision in mCRPC was whether to start a second ARSi or taxane chemotherapy," Epic and Genomic write. Murali Prahalad, CEO of Epic Sciences, said, "The rapid issuance of the draft LCD recommending Medicare coverage highlights the clinical utility and value of this new test in prolonging survival for men with metastatic castration-resistant prostate cancer."

GHDX Genomic Health
$31.29

0.15 (0.48%)

09/29/17
ADAM
09/29/17
NO CHANGE
Target $40
ADAM
Buy
Genomic Health price target raised to $40 from $35 at Canaccord
Following meetings with management, Canaccord analyst Mark Massaro raised his price target on Genomic Health to $40 from $35, citing his expectations for it to achieve double digit growth and accelerate levels of profitability in 2018 and 2019. The analyst believes the shares could hit $40 in early 2018. Massaro reiterated his Buy rating on Genomic Health shares.
12/13/17
JPMS
12/13/17
DOWNGRADE
Target $25
JPMS
Underweight
Genomic Health downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Tycho Peterson downgraded Genomic Health to Underweight and cut his price target for the shares to $25 from $28. The analyst believes the company will be challenged to outgrow a maturing market for its core U.S. invasive breast business. He sees better risk/reward opportunities in other names.
12/20/17
WBLR
12/20/17
DOWNGRADE
WBLR
Market Perform
Genomic Health downgraded to Market Perform from Outperform at William Blair
William Blair analyst Amanda Murphy downgraded Genomic Health to Market Perform citing valuation with the shares rallying recently on reports of a potential sale.
01/10/18
COWN
01/10/18
NO CHANGE
COWN
Market Perform
NICE guidance on Genomic Health test 'somewhat surprising,' says Cowen
Cowen analyst Doug Schenkel noted that the U.K.'s National Institute for Health and Care Excellence, or NICE, reversed a previous decision with new draft guidance that does not recommend Genomic Health's Oncotype test in guiding chemotherapy decisions for breast cancer patients. He finds this "somewhat surprising" given the test's inclusion in other international guidelines and think this could lead to some slight tempering of expectations if finalized. Schenkel has a Market Perform rating on Genomic Health shares.

TODAY'S FREE FLY STORIES

MGLN

Magellan Health

$72.36

7.305 (11.23%)

, ANTM

Anthem

$313.24

1.54 (0.49%)

15:28
02/20/19
02/20
15:28
02/20/19
15:28
Recommendations
Magellan Health, Anthem, Humana, UnitedHealth, WellCare, Centene analyst commentary  »

Magellan's most…

MGLN

Magellan Health

$72.36

7.305 (11.23%)

ANTM

Anthem

$313.24

1.54 (0.49%)

HUM

Humana

$309.26

3.91 (1.28%)

UNH

UnitedHealth

$269.97

-0.29 (-0.11%)

WCG

WellCare

$278.92

1.85 (0.67%)

CNC

Centene

$65.32

0.915 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 07

    Mar

  • 12

    Mar

  • 19

    Mar

  • 28

    May

GM

General Motors

$40.01

0.48 (1.21%)

, VLKAY

Volkswagen

$0.00

(0.00%)

15:20
02/20/19
02/20
15:20
02/20/19
15:20
Periodicals
President Trump continues to weigh EU auto tariffs, WSJ reports »

President Donald Trump…

GM

General Motors

$40.01

0.48 (1.21%)

VLKAY

Volkswagen

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

F

Ford

$8.93

0.105 (1.19%)

FCAU

Fiat Chrysler

$15.07

0.23 (1.55%)

HMC

Honda

$27.71

0.15 (0.54%)

TM

Toyota

$123.04

1.51 (1.24%)

DDAIF

Daimler AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 04

    Mar

  • 27

    Mar

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

TWTR

Twitter

$31.32

-0.32 (-1.01%)

15:20
02/20/19
02/20
15:20
02/20/19
15:20
Periodicals
Twitter changes data on Russian trolls, Bloomberg reports »

Twitter this month made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

GOGO

Gogo

$4.25

0.15 (3.66%)

15:20
02/20/19
02/20
15:20
02/20/19
15:20
Options
Gogo calls active as shares tick higher ahead of earnings »

Gogo calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

CAR

Avis Budget

$29.66

0.08 (0.27%)

15:19
02/20/19
02/20
15:19
02/20/19
15:19
Options
Avis Budget options imply 11.1% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 20

    Mar

  • 21

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
02/20/19
02/20
15:17
02/20/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
02/20/19
02/20
15:16
02/20/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
02/20/19
02/20
15:15
02/20/19
15:15
General news
U.S. Treasury Market Summary »

U.S. Treasury Market…

MRAM

Everspin Technologies

$8.63

1.21 (16.31%)

, INTC

Intel

$51.32

-0.07 (-0.14%)

15:11
02/20/19
02/20
15:11
02/20/19
15:11
Periodicals
Intel calls embedded MRAM ready for high-volume manufacturing, EE Times says »

Intel (INTC), in a paper…

MRAM

Everspin Technologies

$8.63

1.21 (16.31%)

INTC

Intel

$51.32

-0.07 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 14

    Mar

  • 14

    Mar

  • 25

    Mar

  • 26

    Mar

NOG

Northern Oil and Gas

$2.56

0.04 (1.59%)

15:10
02/20/19
02/20
15:10
02/20/19
15:10
Options
Notable call buying in Northern Oil and Gas »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 18

    Mar

15:06
02/20/19
02/20
15:06
02/20/19
15:06
General news
Farm Prices data reported »

December Farm Prices down…

15:06
02/20/19
02/20
15:06
02/20/19
15:06
General news
Farm Prices data reported »

December Farm Prices up…

NTES

NetEase

$231.03

1.48 (0.64%)

15:04
02/20/19
02/20
15:04
02/20/19
15:04
Options
NetEase options imply 10.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ITHUF

iAnthus

$0.00

(0.00%)

15:02
02/20/19
02/20
15:02
02/20/19
15:02
Periodicals
Breaking Periodicals news story on iAnthus »

Hedgeye names iAnthus a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXP

Eagle Materials

$77.88

1.21 (1.58%)

15:00
02/20/19
02/20
15:00
02/20/19
15:00
Options
Notable call buying in Eagle Materials as shares fly to multi-month highs »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

MCS

Marcus

$40.94

1.35 (3.41%)

, NCMI

National CineMedia

$7.13

0.11 (1.57%)

14:57
02/20/19
02/20
14:57
02/20/19
14:57
Hot Stocks
Marcus announces affiliate partnership for Movie Tavern with National CineMedia »

National CineMedia (NCMI)…

MCS

Marcus

$40.94

1.35 (3.41%)

NCMI

National CineMedia

$7.13

0.11 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 02

    Apr

  • 02

    Apr

  • 06

    Jun

14:50
02/20/19
02/20
14:50
02/20/19
14:50
General news
Treasury Action: there wasn't any strong reaction to the FOMC minutes »

Treasury Action: there…

SSNLF

Samsung

$0.00

(0.00%)

14:49
02/20/19
02/20
14:49
02/20/19
14:49
Hot Stocks
Samsung introduces new line of Galaxy S10 phones »

Samsung inroduced a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIPS

Vipshop

$7.28

0.33 (4.75%)

14:49
02/20/19
02/20
14:49
02/20/19
14:49
Options
Vipshop options imply 15.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SSNLF

Samsung

$0.00

(0.00%)

, TMUS

T-Mobile

$72.78

0.27 (0.37%)

14:47
02/20/19
02/20
14:47
02/20/19
14:47
Hot Stocks
Samsung unveils Galaxy Fold »

Samsung Electronics…

SSNLF

Samsung

$0.00

(0.00%)

TMUS

T-Mobile

$72.78

0.27 (0.37%)

T

AT&T

$30.87

0.24 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

  • 20

    Mar

VRTU

Virtusa

$50.50

-0.61 (-1.19%)

14:46
02/20/19
02/20
14:46
02/20/19
14:46
Conference/Events
Virtusa management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 28

    Feb

  • 01

    Mar

  • 04

    Mar

  • 05

    Mar

  • 19

    Mar

ADI

Analog Devices

$106.55

2.34 (2.25%)

14:46
02/20/19
02/20
14:46
02/20/19
14:46
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

  • 13

    Mar

  • 09

    Apr

  • 28

    May

SSNLF

Samsung

$0.00

(0.00%)

14:44
02/20/19
02/20
14:44
02/20/19
14:44
Hot Stocks
Samsung unveils Galaxy Watch Active, Galaxy Fit, and Galaxy Buds »

Samsung Electronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAK

Northern Dynasty

$0.89

0.0029 (0.33%)

14:44
02/20/19
02/20
14:44
02/20/19
14:44
Hot Stocks
Northern Dynasty says Pebble Project Draft Environmental Impact Statement posted »

Northern Dynasty Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSCO

Tractor Supply

$97.56

0.53 (0.55%)

14:42
02/20/19
02/20
14:42
02/20/19
14:42
Conference/Events
Tractor Supply management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 06

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.